Defeating pathogen drug resistance: Guidance from evolutionary theory

27Citations
Citations of this article
115Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Many of the greatest challenges in medicine and public health involve the evolution of drug resistance by pathogens. Recent advances in the theory of natural selection suggest that there are two broad classes of pathogen traits that can be targeted by drugs or vaccines. The first class, consisting of traits that benefit the individual organisms bearing them, causes a strong evolutionary response and the rapid emergence of drug resistance. The second class, consisting of traits that benefit groups of pathogen organisms including the individual provider, causes a weaker evolutionary response and less drug resistance. Although most previous drug development has targeted the first class, it would be advantageous to focus on the second class as targets for drug and vaccine development. Specific examples and test cases are discussed. © 2008 The Author(s).

Cite

CITATION STYLE

APA

Pepper, J. W. (2008, December). Defeating pathogen drug resistance: Guidance from evolutionary theory. Evolution. https://doi.org/10.1111/j.1558-5646.2008.00525.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free